Phenominer Database Results (48 results)

 

Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Record ID Study ID
WKY body weight control condition (for 0 hours) Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1. body mass male 84 days 5 260.0 g 7.0 15.65 body weighing method 0.0 0 103476 2826
WKY body weight 0.9% sodium chloride solution (3 ml) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 9 244.0 g 8.0 24.0 body weighing method 0.0 0 100427 2479
WKY body weight 0.9% sodium chloride solution (3 ml) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 8 317.0 g 10.0 28.28 body weighing method 0.0 0 100430 2479
WKY body weight unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. body mass male 0 days 8 233.0 g 5.0 14.14 body weighing method 0.0 unx 28 days 99938 2378
WKY body weight controlled sodium content diet (0.4 %) (for 122 days) then controlled sodium content diet (1.4 %) (for 210 days) Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81. body mass male 360 days 4 318.0 g 6.65 13.3 body weighing method 0 0 12588 268
WKY body weight left anterior descending coronary artery occlusion then vehicle control condition Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. body mass male 42 days-56 days 30 225.0 g 1.8 9.86 body weighing method 0.0 lad occlusion 0 days 100269 2460
WKY body weight left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. body mass male 266 days-280 days 16 599.0 g 35.0 140.0 body weighing method 0.0 lad occlusion 210 days 100274 2460
WKY body weight in utero condition (30 % of calories) (for 22 days) Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. body mass not specified 1 days 36 4.91 g 0.15 0.9 body weighing method 0.0 0 99074 2218
WKY body weight control condition Ohashi H, et al., Jpn Circ J. 1986 Feb;50(2):140-6. body mass male 245 days 7 373.6 g 11.11 29.4 body weighing method 0.0 0 99849 2338
WKY body weight streptozotocin (60 mg/kg) then benazepril (10 mg/kg/d) then gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 null) Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. body mass male 156 days 10 286.6 g 21.95 69.41 body weighing method 0.0 0 99112 2219
WKY body weight puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 7 245.0 g 9.0 23.81 body weighing method 0.0 PA IV 50mg/kg 15 days 100428 2479
WKY body weight unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then vehicle control condition Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. body mass male 0 days 17 256.0 g 5.0 20.62 body weighing method 0.0 unx 150 days 107446 2378
WKY body weight 0.9% sodium chloride solution (3 ml) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 11 319.0 g 5.0 16.58 body weighing method 0.0 0 100394 2479
WKY body weight controlled in utero environment (100 % of calories) (for 22 days) Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. body mass male 112 days 17 454.0 g 8.0 32.98 body weighing method 0.0 0 99075 2218
WKY body weight sham surgical control condition (for 224 days) Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. body mass male 266 days-280 days 5 562.0 g 22.0 49.19 body weighing method 0.0 lad occlusion sham 210 days 100273 2460
WKY body weight controlled enalapril content drinking water (50 mg/l) (for 22 days) then puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 5 245.0 g 12.0 26.83 body weighing method 0.0 PA IV 50mg/kg 15 days 100429 2479
WKY body weight 0.9% sodium chloride solution (3 ml) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 9 412.0 g 6.0 18.0 body weighing method 0.0 0 100433 2479
WKY body weight controlled enalapril content drinking water (50 mg/l) (for 497 days) then puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 9 395.0 g 7.0 21.0 body weighing method 0.0 PA IV 50mg/kg 490 days 100435 2479
WKY body weight unilateral nephrectomy (for 28 days) then vehicle control condition Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. body mass male 0 days 7 268.0 g 13.0 34.39 body weighing method 0.0 unx 28 days 99935 2378
WKY body weight unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. body mass male 0 days 8 215.0 g 10.0 28.28 body weighing method 0.0 unx 28 days 99936 2378
WKY body weight unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. body mass male 0 days 16 261.0 g 7.0 28.0 body weighing method 0.0 unx 150 days 107448 2378
WKY body weight in utero condition (30 % of calories) (for 22 days) Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. body mass male 112 days 18 436.0 g 11.0 46.67 body weighing method 0.0 0 99076 2218
WKY body weight sham surgical control condition (for 196 days) Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. body mass male 238 days-252 days 12 566.0 g 17.0 58.89 body weighing method 0.0 lad occlusion sham 196 days 100270 2460
WKY body weight left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. body mass male 238 days-252 days 30 617.0 g 52.0 284.82 body weighing method 0.0 lad occlusion 196 days 100272 2460
WKY body weight controlled sodium content diet (0.4 %) (for 122 days) then controlled sodium content diet (1.4 %) (for 210 days) Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81. body mass female 360 days 4 200.8 g 3.45 6.9 body weighing method 0 0 12589 268
WKY body weight left anterior descending coronary artery occlusion then furosemide Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. body mass male 42 days-56 days 20 225.0 g 3.0 13.42 body weighing method 0.0 lad occlusion 0 days 100268 2460
WKY body weight left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. body mass male 238 days-252 days 20 583.0 g 56.0 250.44 body weighing method 0.0 lad occlusion 196 days 100271 2460
WKY body weight vehicle control condition (1 null) Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. body mass male 156 days 10 450.39 g 9.36 29.6 body weighing method 0.0 0 99107 2219
WKY body weight streptozotocin (60 mg/kg) then gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector (40000000000 null) Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. body mass male 156 days 10 261.43 g 21.34 67.48 body weighing method 0.0 0 99109 2219
WKY body weight controlled enalapril content drinking water (50 mg/l) (for 22 days) then puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 10 241.0 g 5.0 15.81 body weighing method 0.0 PA IV 50mg/kg 15 days 100393 2479
WKY body weight controlled enalapril content drinking water (50 mg/l) (between 63 and 77 days) then puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 8 305.0 g 6.0 16.97 body weighing method 0.0 PA IV 50mg/kg 0 100432 2479
WKY body weight puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 8 418.0 g 15.0 42.43 body weighing method 0.0 PA IV 50mg/kg 490 days 100434 2479
WKY body weight 0.9% sodium chloride solution (3 ml) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 10 241.0 g 5.0 15.81 body weighing method 0.0 0 100391 2479
WKY body weight unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days) Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. body mass male 0 days 8 236.0 g 7.0 19.8 body weighing method 0.0 unx 28 days 99937 2378
WKY body weight unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 136 days) and bosentan (100 mg/kg/d) (for 136 days) Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. body mass male 0 days 16 267.0 g 9.0 36.0 body weighing method 0.0 unx 150 days 107449 2378
WKY body weight controlled in utero environment (100 % of calories) (for 22 days) Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. body mass not specified 1 days 26 6.64 g 0.14 0.71 body weighing method 0.0 0 99073 2218
WKY body weight puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 12 323.0 g 5.0 17.32 body weighing method 0.0 PA IV 50mg/kg 0 100395 2479
WKY body weight controlled enalapril content drinking water (50 mg/l) (between 63 and 77 days) then puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 12 312.0 g 4.0 13.86 body weighing method 0.0 PA IV 50mg/kg 0 100396 2479
WKY body weight streptozotocin (60 mg/kg) Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. body mass male 156 days 10 259.65 g 18.96 59.96 body weighing method 0.0 0 99108 2219
WKY body weight streptozotocin (60 mg/kg) then gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 null) Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. body mass male 156 days 10 295.56 g 21.89 69.22 body weighing method 0.0 0 99110 2219
WKY body weight streptozotocin (60 mg/kg) then benazepril (10 mg/kg/d) Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. body mass male 156 days 10 287.24 g 20.18 63.81 body weighing method 0.0 0 99111 2219
WKY body weight puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 11 249.0 g 11.0 36.48 body weighing method 0.0 PA IV 50mg/kg 15 days 100392 2479
WKY body weight puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 9 297.0 g 4.0 12.0 body weighing method 0.0 PA IV 50mg/kg 0 100431 2479
WKY body weight unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days) Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. body mass male 0 days 6 229.0 g 6.0 14.7 body weighing method 0.0 unx 28 days 99939 2378
WKY body weight unilateral nephrectomy (for 150 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 136 days) Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. body mass male 0 days 17 274.0 g 6.0 24.74 body weighing method 0.0 unx 150 days 107447 2378
WKY body weight unilateral nephrectomy (for 150 days) then vehicle control condition Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. body mass male 0 days 11 408.0 g 10.0 33.17 body weighing method 0.0 unx 150 days 107445 2378
WKY body weight sham surgical control condition Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. body mass male 42 days-56 days 12 223.0 g 1.4 4.85 body weighing method 0.0 lad occlusion 0 days 100267 2460
WKY body weight left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. body mass male 266 days-280 days 32 574.0 g 38.0 214.96 body weighing method 0.0 lad occlusion 210 days 100275 2460